These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 3276392)
21. Bax expression in benign and malignant thyroid tumours: dysregulation of wild-type P53 is associated with a high Bax and P21 expression in thyroid carcinoma. Hermann S; Sturm I; Mrozek A; Klosterhalfen B; Hauptmann S; Dörken B; Daniel PT Int J Cancer; 2001 Jun; 92(6):805-11. PubMed ID: 11351299 [TBL] [Abstract][Full Text] [Related]
22. Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas. Soda G; Antonaci A; Bosco D; Nardoni S; Melis M J Exp Clin Cancer Res; 1999 Sep; 18(3):363-7. PubMed ID: 10606183 [TBL] [Abstract][Full Text] [Related]
23. Expression of the 21,000 molecular weight ras protein in a spectrum of benign and malignant human mammary tissues. Ohuchi N; Thor A; Page DL; Hand PH; Halter SA; Schlom J Cancer Res; 1986 May; 46(5):2511-9. PubMed ID: 3084069 [TBL] [Abstract][Full Text] [Related]
24. p27kip1 expression distinguishes papillary hyperplasia in Graves' disease from papillary thyroid carcinoma. Erickson LA; Yousef OM; Jin L; Lohse CM; Pankratz VS; Lloyd RV Mod Pathol; 2000 Sep; 13(9):1014-9. PubMed ID: 11007042 [TBL] [Abstract][Full Text] [Related]
25. [Immunohistochemical study on oncogene product ras p 21 in thyroid carcinoma]. Mochizuki Y; Nakayama I; Noguchi S Nihon Gan Chiryo Gakkai Shi; 1989 Aug; 24(8):1539-44. PubMed ID: 2681472 [TBL] [Abstract][Full Text] [Related]
26. Preparation of anti-ras Mr 21,000 protein monoclonal antibodies and immunohistochemical analyses on expression of ras genes in human stomach and thyroid cancers. Yoshida K; Hamatani K; Koide H; Ikeda H; Nakamura N; Akiyama M; Tsuchiyama H; Nakayama E; Shiku H Cancer Res; 1988 Oct; 48(19):5503-9. PubMed ID: 3046740 [TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical and immunoblot analyses of ras-p21 expression in lung carcinomas. Koshiishi Y; Noguchi M; Nakajima T; Hirohashi S; Shimosato Y; Hayata Y Acta Pathol Jpn; 1989 Oct; 39(10):643-7. PubMed ID: 2686349 [TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical demonstration of thyrotropin (TSH)-receptor in normal and diseased human thyroid tissues using monoclonal antibody against recombinant human TSH-receptor protein. Mizukami Y; Hashimoto T; Nonomura A; Michigishi T; Nakamura S; Noguchi M; Matsukawa S J Clin Endocrinol Metab; 1994 Aug; 79(2):616-9. PubMed ID: 8045985 [TBL] [Abstract][Full Text] [Related]
29. Immunocytochemical localization of p21 ras gene product in human hepatoma cell lines and corresponding tumors in athymic mice. Matarazzo M; Faraggiana T; Donato MF; Paronetto F J Exp Pathol; 1987; 3(3):305-15. PubMed ID: 2835467 [TBL] [Abstract][Full Text] [Related]
30. Expression of intermediate filament proteins in normal and diseased thyroid glands. Buley ID; Gatter KC; Heryet A; Mason DY J Clin Pathol; 1987 Feb; 40(2):136-42. PubMed ID: 3546391 [TBL] [Abstract][Full Text] [Related]
31. Laminin immunodetection in tumorous and nontumorous disorders of human thyroid. Charpin C; Kopp F; Pourreau-Schneider N; Lissitzky JC; Lavaut MN; Martin PM; Toga M Bull Cancer; 1985; 72(1):6-15. PubMed ID: 3886045 [TBL] [Abstract][Full Text] [Related]
32. Ras oncogene p21 levels parallel malignant potential of different human colonic benign conditions. Michelassi F; Leuthner S; Lubienski M; Bostwick D; Rodgers J; Handcock M; Block GE Arch Surg; 1987 Dec; 122(12):1414-6. PubMed ID: 3318757 [TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical analysis of the ras p21 oncoprotein in Hashimoto's thyroiditis. Kyriakoy D; Karkavitsas N; Eliopoulos G; Spandidos DA Anticancer Res; 1992; 12(4):1189-94. PubMed ID: 1503408 [TBL] [Abstract][Full Text] [Related]
34. [A case report of primary triple cancers in the thyroid, stomach and rectum with evidence of variable oncoprotein expressions]. Shibutani Y; Inoue D; Sugawa H; Mori T Nihon Naibunpi Gakkai Zasshi; 1994 Oct; 70(8):951-6. PubMed ID: 8001692 [TBL] [Abstract][Full Text] [Related]
35. Monoclonal antibodies of predefined specificity detect activated ras gene expression in human mammary and colon carcinomas. Hand PH; Thor A; Wunderlich D; Muraro R; Caruso A; Schlom J Proc Natl Acad Sci U S A; 1984 Aug; 81(16):5227-31. PubMed ID: 6382261 [TBL] [Abstract][Full Text] [Related]
36. [Ghrelin expression in the tissues of different thyroid diseases]. Zhang YF; Wang HN; Hong TP Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Apr; 38(2):193-6. PubMed ID: 16617365 [TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical localization of thyroglobulin (Tg), thyroxine (T4), and triiodothyronine (T3) in thyroid diseases. Stefăneanu L; Taşcă C Acta Histochem; 1986; 78(1):7-18. PubMed ID: 2421518 [TBL] [Abstract][Full Text] [Related]
38. Similarity of expression of low molecular weight G proteins smg p21A and ras p21 in normal and malignant human tissues. Takayama K; Furukawa K; Abe K; Kawase Y; Mizoguchi A; Kikuchi A; Takai Y; Matsui Y; Teranishi Y; Nakayama E Cancer Res; 1991 Apr; 51(8):2223-8. PubMed ID: 1901241 [TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical demonstration of epidermal growth factor and c-myc oncogene product in normal, benign and malignant thyroid tissues. Mizukami Y; Nonomura A; Hashimoto T; Michigishi T; Noguchi M; Matsubara F; Yanaihara N Histopathology; 1991 Jan; 18(1):11-8. PubMed ID: 2013457 [TBL] [Abstract][Full Text] [Related]
40. Molecular abnormalities of p53, MDM2, and H-ras in synovial sarcoma. Oda Y; Sakamoto A; Satio T; Kawauchi S; Iwamoto Y; Tsuneyoshi M Mod Pathol; 2000 Sep; 13(9):994-1004. PubMed ID: 11007040 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]